The sesquiterpene lactone dihydroartemisinin (DHA), a drug artemisinin, is cytotoxic to human tumor cells. Tre duced a breakdown of the mitochondrial transmembran caspases, and DNA fragmentation indicative of apopto caspase-8 did not alter apoptosis rates in Jurkat cells, ov ytoto tein B A-ind f Bak in ce the f caven uced ption bran
Thesis (Master's)--University of Washington, 2015Artemisinin generates cytotoxic free radicals when ...
<div><p>Despite recent advances in the therapy of non-small cell lung cancer (NSCLC), the chemothera...
Tumor hypoxia is one main biological factor that drives resistance to chemotherapy and radiotherapy....
Abstract Background Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, isolated f...
Background: Dihydroartemisinin (DHA) is a semisynthetic derivative of artemisinin and has antiprolif...
Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, has recently shown antitumor a...
Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, has recently shown antitumor a...
Despite recent advances in chemotherapy and surgical resection, the 5-year survival rate of esophage...
Dihydroartemisinin (DHA), a front-line antimalarial herbal compound, has been shown to possess promi...
It has previously been reported that dihydroartemisinin (DHA) is an effective novel anticancer compo...
Liver cancer ranks in prevalence and mortality among top five cancers worldwide. Accumulating intere...
This report is designed to explore the molecular mechanism by which dihydroartemisinin (DHA) and ion...
This report is designed to explore the molecular mechanism by which dihydroartemisinin (DHA) and ion...
Artemisinin and its main active metabolite dihydroartemisinin, clinically used antimalarial agents w...
<div><p>Artemisinin and its main active metabolite dihydroartemisinin, clinically used antimalarial ...
Thesis (Master's)--University of Washington, 2015Artemisinin generates cytotoxic free radicals when ...
<div><p>Despite recent advances in the therapy of non-small cell lung cancer (NSCLC), the chemothera...
Tumor hypoxia is one main biological factor that drives resistance to chemotherapy and radiotherapy....
Abstract Background Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, isolated f...
Background: Dihydroartemisinin (DHA) is a semisynthetic derivative of artemisinin and has antiprolif...
Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, has recently shown antitumor a...
Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, has recently shown antitumor a...
Despite recent advances in chemotherapy and surgical resection, the 5-year survival rate of esophage...
Dihydroartemisinin (DHA), a front-line antimalarial herbal compound, has been shown to possess promi...
It has previously been reported that dihydroartemisinin (DHA) is an effective novel anticancer compo...
Liver cancer ranks in prevalence and mortality among top five cancers worldwide. Accumulating intere...
This report is designed to explore the molecular mechanism by which dihydroartemisinin (DHA) and ion...
This report is designed to explore the molecular mechanism by which dihydroartemisinin (DHA) and ion...
Artemisinin and its main active metabolite dihydroartemisinin, clinically used antimalarial agents w...
<div><p>Artemisinin and its main active metabolite dihydroartemisinin, clinically used antimalarial ...
Thesis (Master's)--University of Washington, 2015Artemisinin generates cytotoxic free radicals when ...
<div><p>Despite recent advances in the therapy of non-small cell lung cancer (NSCLC), the chemothera...
Tumor hypoxia is one main biological factor that drives resistance to chemotherapy and radiotherapy....